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• Heart’s inability to pump
blood to maintain flow 
needed by the body (Ma et
al., 2020)
• Classified by degree of
ejection fraction (EF),
whether reduced with EF 
<50% or preserved with 
EF >50% (Ma et al., 2020)
Why CHF? 
• CHF affects about 40
million people globally (Ma
et al., 2020)
• More than 6.5 million
people are diagnosed with 
CHF in the United States 
(Hsu et al., 2017)
• CHF creates a financial 
burden for a health system
with limited resources,
“resulting in one of the
greatest health,
organizational and 
economic issues facing 
medical services globally” 
(Verdu-Rotellar et al.,
2020, p. 474)
Signs & Symptoms 
Clinical presentation varies 
dependent on cause: 
congestion or decreased 
cardiac output (CO) 
• Congestion symptoms: 
orthopnea, dyspnea, 
paroxysmal nocturnal
dyspnea, edema, JVD 
hemoptysis, weight gain 
• Low CO symptoms: 
fatigue, weakness,
exercise intolerance, low 
urine output, low blood 
pressure 
(Aguanno & Samson, 2017) 
Pathophysiology Clinical Significance 
Pathophysiology of CHF is 
• Patients 65 years or older
dependent upon the cause:
account for 80% and 90% of
diastolic or systolic, left sided or
heart failure-related 
ride sided, preserved EF (HFpEF) 
hospitalizations and deaths
or reduced EF (HFrEF) 
(Son et al., 2020)
• “HFpEF involves left 
• “Despite advances in early 
ventricular diastolic
diagnosis and treatment of
dysfunction, resulting from
heart failure, its debilitating 
impaired left ventricular
characteristics result in
relaxation and increased 
substantial morbidity and a
stiffness, which contributes to
high burden of long-term
elevated left atrial pressure” 
management” (Son et al.,
(Normand et al., 2019, p.
2020, p. 1)
1046) 
• Blood remains upstream of
ventricles, which results in Nursing Care 
increased filling pressures 
• “Nurse-led heart failure(congestion) that impair organ
management programs function (Harjola et al., 2018)
reduced the heart failure• “Pulmonary congestion and 
specific readmission rate bypulmonary edema occur when 
32%” (Son et al., 2020, p. 2)blood remains upstream of the
• Evidence recommends left ventricle due to elevated 
patients with EF <35% and left atrial pressure; congestion 
symptoms despite >3of organs in abdominal cavity
months of regimented, ensues when blood remains
medical treatment have aupstream of the right ventricle” 
cardioverter defibrillator(Harjola et al., 2018, p. 3)
implanted to reduce sudden
• CHF causes inadequate
cardiac death and mortalityperfusion due to low cardiac
(Brink, 2018)output, which results in tissue
• Joint Commissionhypoxia, cell death, and organ
recommends inclusion ofdysfunction (Harjola et al.,
family caregivers in2018)
discharge education (Son et
Table below shows classifications of
al., 2020, p. 11)
CHF based on EF% remaining 
(Aguanno & Samson, 2017)
Risk Factors 
Treatments
• Remove excess fluid in patients with volume overload with 
loop diuretics (Harjola et al., 2018)
• Pharmacological therapies include “angiotensin converting 
enzyme inhibitors (ACEs) and, when ACEs are contraindicated, 
angiotensin receptor blockers (ARBs) and loop diuretics” 
which have been shown to reduce mortality and
hospitalizations (Aguanno & Samson, 2018, p. 8) 
• “Unless contraindicated, all patients with a reduced EF should
receive a beta-blocker and an ACE inhibitor or ARB” (Brink, 
2018, p. 22)
• “Vasodilators improve ventricular function by reducing 
afterload and decrease symptoms by reducing cardiac filling 
pressure. Nitrates (nitroglycerin, nitroprusside) are direct-
acting vasodilators” (Harjola et al., 2018, p. 13)
• Early recognition of symptoms/ worsening of symptoms with 
consecutive interventions helps minimize hospitalizations 
(Vuckovic et al., 2020)
• Digoxin can help to reduce exercise intolerance but has no
effect on reducing mortality (Brink, 2018)
• Inotropic agents, such as Dobutamine and Milrinone, can be
used in severe states of hypoperfusion (Harjola et al., 2018)
• Patients should be enrolled in cardiac rehabilitation programs/ 
participate in home exercise programs (Aggarwal et al., 2018)
• Left ventricular assist devices and cardiac transplants may be
beneficial to patients with refractory symptoms (Brink, 2018)
Complications 
Heart failure decompensation can be precipitated by factors 
including:
• respiratory infections 
• transgression in dietary restrictions 
• non-compliance with pharmacological therapies 
• hypertension 
• cardiac arrhythmias 
(Verdu-Rotellar et al., 2020) 
Other complications:
• Cardiorenal syndrome: results in kidney injury and 
worsening dysfunction due to “inflammatory mediators,
iatrogenic damage (contrast media, nephrotoxic medication),
low cardiac output and elevated intra-abdominal pressure” 
(Harjola et al., 2018, p. 6)
• Atrial fibrillation (Afib): up to 50% of patients with CHF will
develop Afib or wide QRS complexes (Normand et al., 2019)
• Atrial fibrillation with rapid ventricular rate (Afib w/ RVR):
patients with CHF are at an increased risk for Afib w/ RVR,
which pathologically causes “loss of atrioventricular
synchrony, and decrease in the contribution of atrial 
contraction to ventricular filling” (Verdu-Rotellar et al., 2020,
p. 478) 
• Pulmonary hypertension (pulm HTN): up to 80% of patients 
with CHF have pulm HTN due to increasing left atrial and 
pulmonary venous pressures caused by diastolic dysfunction
(Ma et al., 2020)
The below picture illustrates the effects of congestion related to
heart failure decompensation on end organs of the body. LV, left 
ventricle (Harjola et al., 2018) 
Conclusions 
• “Health-related quality of
life is known to be much 
worse in people with 
heart failure than those
with other chronic
conditions” (Son et al.,
2020. p. 1) 
• Evidence has shown that
CHF can be prevented by
the maintenance of
lifestyle choices and 
modifications (Aggarwal
et al., 2018) 




• “With the rapidly
increasing number of
older adults and the
irreversible nature of
heart failure, it poses an
overwhelming burden
requiring further efforts to
reduce adverse health
outcomes and improve
quality of life” (Son et al.,
2020, p. 2)
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